Procter & Gamble Health standalone net profit rises 54.63% in the March 2026 quarter
(27 May 2026)

Back
Net profit of Procter & Gamble Health rose 54.63% to Rs 94.60 crore in the quarter ended March 2026 as against Rs 61.18 crore during the previous quarter ended March 2025. Sales rose 19.12% to Rs 370.45 crore in the quarter ended March 2026 as against Rs 310.99 crore during the previous quarter ended March 2025.

For the full year,net profit rose 39.46% to Rs 326.91 crore in the year ended March 2026 as against Rs 234.41 crore during the previous year ended March 2025. Sales rose 50.72% to Rs 1407.97 crore in the year ended March 2026 as against Rs 934.17 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales370.45310.99 19 1407.97934.17 51
OPM %36.6026.02 -32.4334.08 -
PBDT139.3883.90 66 473.45328.31 44
PBT133.2178.53 70 449.86311.62 44
NP94.6061.18 55 326.91234.41 39

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew